Recruiting studies: Neutropenia Low White Blood Cell Count

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746 Cologne Cohort of Neutropenic Patients (CoCoNut)
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT01821456 Short Antibiotic Treatment in High Risk Febrile Neutropenia
NA · 4 location(s) · University Health Network, Toronto · NCT05786495 Next-Generation-Sequencing Approach to Neutropenic Sepsis
Phase N/A · 6 location(s) · Boris Böll · NCT05815628 Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2 · 1 location(s) · Affiliated Hospital of Nantong University · NCT07205536 Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Phase N/A · 1 location(s) · Kaplan Medical Center · NCT06908616 Luspatercept for Clonal Cytopenias of Uncertain Significance
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT06788691 Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756 Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
Phase 2 · 1 location(s) · West Virginia University · NCT05537896 Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
NA · 1 location(s) · Valeria Cento · NCT07372131 Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NA · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT04270786 Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
NA · 1 location(s) · Alexandria University · NCT07300735 Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06616571 Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
Phase N/A · 1 location(s) · Shanxi Bethune Hospital · NCT07204522 Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Phase N/A · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07434063 Breath Analysis for the Detection of Invasive Fungal Infections
Phase N/A · 1 location(s) · University of Zurich · NCT06537726 Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Maligna
Phase 4 · 1 location(s) · Gadjah Mada University · NCT07016165 Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Phase N/A · 3 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07277387 Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With
Phase 4 · 1 location(s) · Beneficência Portuguesa de São Paulo · NCT06342115 Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapi
NA · 2 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07051525 Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Phase 4 · 1 location(s) · Tufts Medical Center · NCT05626530 Study of Trilaciclib and Lurbinectidin
Phase 2 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05578326 Serial Blood Count Study
EARLY_Phase 1 · 1 location(s) · University of Washington · NCT07066085 the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer
Phase 2 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07380646 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · 114 location(s) · X4 Pharmaceuticals · NCT06056297 Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Phase 4 · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05926063 The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06913998 Shwachman Diamond Syndrome Registry and Study
Phase N/A · 4 location(s) · Boston Children's Hospital · NCT06056908 A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00967785 Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance
Phase 4 · 1 location(s) · Centre Hospitalier Universitaire Vaudois · NCT06293677

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.